Literature DB >> 26660314

Protective effects of ellagic acid in D-galactosamine-induced kidney damage in rats.

Adnan Ayhanci1, Mustafa Cengiz2, H Mehtap Kutlu3, Djanan Vejselova3.   

Abstract

D-Galactosamine (D-GalN), which is an established experimental toxin, primarily causes liver injury by the generation of free radicals and depletion of UTP nucleotides. D-GalN intoxication also induces renal dysfunction thus, renal failure is often associated with the end-stage of the liver damage. We have investigated both preventive and curative effects of ellagic acid (EA) in this study. EA treatment at a gavage dose of 20 mg/kg body weight was administered before and after intraperitoneal (i.p.) injection of D-GalN at a dose of 750 mg/kg. Tissue and blood samples of animals were collected for morphological and biochemical evaluations. Our study results suggest that EA treatment both prior to and after the toxin administration successfully altered the toxic effects on the rats. Moreover, pre-treatment of EA was more protective than post-treatment indicated by histopathological and biochemical values. In conclusion, EA treatment both before and after D-GalN intoxication could protect kidney tissues against D-GalN induced oxidative stress.

Entities:  

Keywords:  Apoptotic markers; D-GalN; Ellagic acid; Renal failure

Year:  2015        PMID: 26660314      PMCID: PMC5023550          DOI: 10.1007/s10616-015-9928-z

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  30 in total

1.  Hepatoprotective effects of purple potato extract against D-galactosamine-induced liver injury in rats.

Authors:  Kyu-Ho Han; Naoto Hashimoto; Ken-Ichiro Shimada; Mitsuo Sekikawa; Takahiro Noda; Hiroaki Yamauchi; Makoto Hashimoto; Hideyuki Chiji; David L Topping; Michihiro Fukushima
Journal:  Biosci Biotechnol Biochem       Date:  2006-06       Impact factor: 2.043

2.  Antiperoxidative and anti-apoptotic effects of lycopene and ellagic acid on cyclophosphamide-induced testicular lipid peroxidation and apoptosis.

Authors:  Gaffari Türk; Ali Osman Ceribaşi; Fatih Sakin; Mustafa Sönmez; Ahmet Ateşşahin
Journal:  Reprod Fertil Dev       Date:  2010       Impact factor: 2.311

3.  Selective uridine triphosphate deficiency induced by D-galactosamine in liver and reversed by pyrimidine nucleotide precursors. Effect on ribonucleic acid synthesis.

Authors:  D O Keppler; J Pausch; K Decker
Journal:  J Biol Chem       Date:  1974-01-10       Impact factor: 5.157

4.  Experimental hepatitis induced by D-galactosamine.

Authors:  D Keppler; R Lesch; W Reutter; K Decker
Journal:  Exp Mol Pathol       Date:  1968-10       Impact factor: 3.362

5.  Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure.

Authors:  P Javlé; J Yates; H G Kynaston; K F Parsons; S A Jenkins
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

6.  Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice.

Authors:  K L Khanduja; R K Gandhi; V Pathania; N Syal
Journal:  Food Chem Toxicol       Date:  1999-04       Impact factor: 6.023

7.  Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: a dose-dependent study.

Authors:  N Al-Kharusi; H A Babiker; S Al-Salam; M I Waly; A Nemmar; I Al-Lawati; J Yasin; S Beegam; B H Ali
Journal:  Eur Rev Med Pharmacol Sci       Date:  2013-02       Impact factor: 3.507

8.  Carnitine palmitoyltransferase I. Inhibition by D-galactosamine and role of phospholipids.

Authors:  O Sire; M Mangeney; J Montagne; R Nordmann; J Nordmann
Journal:  Eur J Biochem       Date:  1983-11-02

9.  Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid.

Authors:  Gaffari Türk; Ahmet Ateşşahin; Mustafa Sönmez; Ali Osman Ceribaşi; Abdurrauf Yüce
Journal:  Fertil Steril       Date:  2007-08-06       Impact factor: 7.329

10.  Amelioration of galactosamine-induced nephrotoxicity by a protein isolated from the leaves of the herb, Cajanus indicus L.

Authors:  Mahua Sinha; Prasenjit Manna; Parames C Sil
Journal:  BMC Complement Altern Med       Date:  2007-04-25       Impact factor: 3.659

View more
  4 in total

Review 1.  Ellagic acid in suppressing in vivo and in vitro oxidative stresses.

Authors:  Alam Zeb
Journal:  Mol Cell Biochem       Date:  2018-01-31       Impact factor: 3.396

2.  Ellagic acid attenuates arsenic induced neuro-inflammation and mitochondrial dysfunction associated apoptosis.

Authors:  Fakiha Firdaus; Mohd Faraz Zafeer; Ehraz Anis; Masood Ahmad; Mohammad Afzal
Journal:  Toxicol Rep       Date:  2018-03-09

3.  Synaptic plasticity and cognitive impairment consequences to acute kidney injury: Protective role of ellagic acid.

Authors:  Alireza Sarkaki; Sarkaki Hoseinynejad; Maryam Khombi Shooshtari; Mohammad Rashno
Journal:  Iran J Basic Med Sci       Date:  2022-05       Impact factor: 2.532

4.  Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK.

Authors:  Jozaa Z ALTamimi; Ghedeir M Alshammari; Nora A AlFaris; Reham I Alagal; Dalal H Aljabryn; Norah A Albekairi; Mahmoud Ahmad Alkhateeb; Mohammed Abdo Yahya
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.